Patents Assigned to Bayer
  • Publication number: 20080281025
    Abstract: The present invention relates to hybrid organic-inorganic polyisocyanates for the preparation of organic-inorganic coating compositions and adhesives.
    Type: Application
    Filed: May 7, 2008
    Publication date: November 13, 2008
    Applicant: Bayer MaterialScience AG
    Inventors: Arno Nennemann, Steffen Hofacker, Markus Mechtel, Thomas Klimmasch
  • Publication number: 20080282429
    Abstract: The present invention relates to transplastomic plants free of the selectable marker gene, to a method of obtaining such plants and to the vectors used.
    Type: Application
    Filed: January 3, 2006
    Publication date: November 13, 2008
    Applicant: BAYER CROPSCIENCE S.A.
    Inventors: Ghislaine Tissot, Manuel Dubald, Jean-Marc Ferullo
  • Patent number: 7449459
    Abstract: The invention relates to compounds of general formula I as well as the production and use thereof as a medication.
    Type: Grant
    Filed: March 23, 2007
    Date of Patent: November 11, 2008
    Assignee: Bayer Schering Pharma AG
    Inventors: Bernd Buchmann, Dirk Kosemund, Bernd Menzenbach, Martin Fritsch
  • Patent number: 7449198
    Abstract: The present invention relates to stable salts of O-acetylsalicylic acid with basic amino acids, a process for their preparation and their use as medicaments.
    Type: Grant
    Filed: August 9, 2004
    Date of Patent: November 11, 2008
    Assignee: Bayer Healthcare AG
    Inventors: Gerhard Franckowiak, Hubert Appolt, Gregor Leifker, Hans-Peter Wirges, Wolfram Ledwoch
  • Patent number: 7449623
    Abstract: Nucleic acid molecules are described encoding a starch granule-bound protein from rice as well as methods and recombinant DNA molecules for the production of transgenic plant cells and plants synthesizing a modified starch. Moreover, the plant cells and plants resulting from those methods as well as the starch obtainable therefrom are described.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: November 11, 2008
    Assignee: Bayer Bioscience GmbH
    Inventor: Claus Frohberg
  • Publication number: 20080276336
    Abstract: The present invention relates to a method for identifying proteins involved in the phosphorylation of starch and nucleic acids which code for such proteins. The present invention further relates to plant cells and plants which exhibit an altered activity of a protein which can be identified using the method according to the invention. Plant cells and plants of this type synthesise a modified starch. The present invention therefore also relates to the starch synthesised by the plant cells and plants according to the invention as well as to methods for the manufacture of this starch and to the manufacture of starch derivatives of this modified starch.
    Type: Application
    Filed: March 4, 2005
    Publication date: November 6, 2008
    Applicant: BAYER CROPSCIENCE GMBH
    Inventors: Claus Frohberg, Oliver Koetting, Gerhard Ritte, Martin Steup
  • Publication number: 20080274882
    Abstract: The present invention relates to novel active compound combinations comprising, as active compounds, firstly an active compound from the group of the neonicotinoids clothianidin, imidacloprid, thiacloprid, dinotefuran, acetamiprid, nitenpyram and thiamethoxam and, secondly, at least one active compound selected from the group of the strobilurin fungicides picoxystrobin, pyraclostrobin, dimoxystrobin, metominostrobin and orysastrobin, to their use as pesticides and as seed dressings for the treatment of seed, to methods for controlling pests and for protecting seed and to seed treated with the active compound combinations according to the invention.
    Type: Application
    Filed: December 17, 2005
    Publication date: November 6, 2008
    Applicant: Bayer CropScience AG
    Inventors: Peter-Wilhelm Krohn, Rolf Christian Becker, Heike Hungenberg
  • Publication number: 20080274447
    Abstract: A biosensor system, method and apparatus are provided for implementing threshold based correction functions for biosensors. A primary measurement of an analyte value is obtained. A secondary measurement of a secondary effect is obtained and is compared with a threshold value. A correction function is identified responsive to the compared values. The correction function is applied to the primary measurement of the analyte value to provide a corrected analyte value. The correction method uses correction curves that are provided to correct for an interference effect. The correction curves can be linear or non-linear. The correction method provides different correction functions above and below the threshold value. The correction functions may be dependent or independent of the primary measurement that is being corrected. The correction functions may be either linear or nonlinear.
    Type: Application
    Filed: March 31, 2005
    Publication date: November 6, 2008
    Applicant: BAYER HEALTHCARE LLC
    Inventor: George A. Mecklenburg
  • Patent number: 7446144
    Abstract: A thermoplastic molding composition suitable for preparing articles by thermoforming is disclosed. The molding composition that comprise A) branched, aromatic poly(ester)carbonate, B) graft polymer, C) an optional vinyl(co)polymer and or polyalkylene terephthalate, D) at least one flame retarding phosphorous compound selected from the group consisting of mono- and oligomeric phosphorus and phosphonic acid esters, phosphonate amines and phosphazenes and E) talc, is characterized in that its flexural modulus at room temperature is at least 3000 N/mm2 and that its falling dart energy at break, at ?30° C., is at least 40.0 J. Sheets extruded of the composition are suitable for making useful articles by thermoforming.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: November 4, 2008
    Assignees: Bayer MaterialScience LLC, Bayer MaterialScience AG
    Inventors: Eckhard Wenz, Pierre Moulinié, Thomas Eckel, Vera Buchholz, Dieter Wittmann, Bruce Hager, Fred J. Zaganiacz
  • Patent number: 7445770
    Abstract: The invention relates to an aqueous polyurethane dispersion suitable for use in personal care products, the dispersed polyurethane comprising the reaction products of: A) a prepolymer according to the formula: wherein R1 represents a bivalent radical of a dihydroxyl functional compound, R2 represents a hydrocarbon radical of an aliphatic or cycloaliphatic polyisocyanate, R3 represents a radical of a low molecular weight diol, optionally substituted with ionic groups, n is from 0 to 5, and m is >1; B) at least one chain extender according to the formula: H2N—R4—NH2 wherein R4 represents an alkylene or alkylene oxide radical not substituted with ionic or potentially ionic groups; and C) at least one chain extender according to the formula: H2N—R5—NH2 wherein R5 represents an alkylene radical substituted with ionic or potentially ionic groups.
    Type: Grant
    Filed: March 14, 2007
    Date of Patent: November 4, 2008
    Assignee: Bayer MaterialScience LLC
    Inventors: Yuliya Berezkin, Peter D. Schmitt, Serkan Unal
  • Publication number: 20080267849
    Abstract: Processes comprising: providing a gas stream comprising hydrogen chloride and carbon monoxide; and oxidizing at least a portion of the carbon monoxide in the gas stream in the presence of a catalyst to form a product gas comprising hydrogen chloride and carbon dioxide; wherein the catalyst comprises tin dioxide and a ruthenium compound comprising at least one element selected from the group consisting of oxygen and chlorine.
    Type: Application
    Filed: April 28, 2008
    Publication date: October 30, 2008
    Applicant: Bayer MaterialScience AG
    Inventors: Michel Haas, Frank Gerhartz, Aurel Wolf, Oliver Felix-Karl Schluter
  • Publication number: 20080269056
    Abstract: A mixture, which comprises (A) thidiazuron (or thidiazuron and diuron), and (B) one or more compounds from the group of the N-phenylsulfonyl(het)arylamides, if appropriate also in salt form, of the formula below: in which R21 is cyclopropyl and R22 is H, R21 is cyclopropyl and R22 is 5-Cl, R21 is ethyl and R22 is H, R21 is isopropyl and R22 is 5-Cl or R21 is isopropyl and R22 is H; is suitable for use as a defoliant, in particular in crops of cotton.
    Type: Application
    Filed: April 24, 2008
    Publication date: October 30, 2008
    Applicant: Bayer CropScience AG
    Inventors: Christopher Rosinger, Frank Ziemer, Udo Bickers
  • Publication number: 20080268046
    Abstract: The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
    Type: Application
    Filed: April 29, 2005
    Publication date: October 30, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: Susanne Zuleger, Peter Serno, Helmut Haning, Kerstin Pauli, Roland Heinig
  • Publication number: 20080267857
    Abstract: Oxidation catalysts comprising one or more ruthenium compounds and one or more promoters selected from the group consisting of zirconium halides, alkali metal halides, alkaline earth metal halides and lanthanum compounds, wherein the molar ratio of promoter to ruthenium is in the range of from 1:100 to 1:1; as well as processes for their preparation and use.
    Type: Application
    Filed: April 23, 2008
    Publication date: October 30, 2008
    Applicant: Bayer MaterialScience AG
    Inventors: Oliver Felix-Karl Schlueter, Leslaw Mleczko, Aurel Wolf, Stephan Schubert
  • Publication number: 20080269468
    Abstract: The present invention relates to a process and apparatus for purifying a molecule of interest from a heterogeneous clarified fluid mixture. The apparatus of the invention generally comprises a continuous perfusion fermentation system, a continuous particle removal system integrated with the perfusion fermentation system; and a continuous purification system integrated with the particle removal system, which is maintained under sterile conditions. The process comprises filtering a heterogeneous clarified fluid mixture by continuous ultrafiltration at a specific flow rate below the transition point of the molecule of interest in the pressure-dependent region of the flux versus TMP curve, wherein the specific flow rate is maintained substantially constant throughout the continuous ultrafiltration.
    Type: Application
    Filed: September 30, 2005
    Publication date: October 30, 2008
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Jens Holger Vogel, Roberto Giovannini, Konstantin B. Konstantinov, Huong My Nguyen, Paul Wu
  • Publication number: 20080269300
    Abstract: The present application relates to novel phenylaminothiazole derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of hypertension and other cardiovascular disorders.
    Type: Application
    Filed: August 30, 2005
    Publication date: October 30, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Jens-Kerim Erguden, Gunter Karig, Ulrich Rosentreter, Barbara Albrecht, Kerstin Henninger, Joachim Hutter, Nicole Diedrichs, Peter Nell, Sabine Arndt, Walter Hubsch, Andreas Knorr, Karl-Heinz Schlemmer, Dirk Brohm
  • Publication number: 20080264253
    Abstract: Processes comprising: providing a crude gas stream having a temperature not exceeding 40° C., the crude gas stream comprising hydrogen chloride and at least one organic impurity; condensing at least a portion of the at least one organic impurity from the crude gas stream at a temperature not exceeding 0° C. to form a prepurified gas stream and a condensate comprising condensed organic impurity; subjecting at least a portion of the prepurified gas stream to adsorption on an adsorption medium to provide a purified gas stream; and separating the condensate into at least a head gas stream comprising residual hydrogen chloride and a sump stream comprising at least a portion of the condensed organic impurity.
    Type: Application
    Filed: April 28, 2008
    Publication date: October 30, 2008
    Applicant: Bayer MaterialScience AG
    Inventors: Ole Brettschneider, Knud Werner
  • Publication number: 20080269263
    Abstract: The present invention relates to novel active substance combinations which contain spiroxamine, which is known, a known azole and a known carboxamide and which are very suitable for controlling undesired phytopathogenic fungi.
    Type: Application
    Filed: September 3, 2005
    Publication date: October 30, 2008
    Applicant: Bayer Cropscience AG
    Inventors: Peter Dahmen, Ulrike Wachendorff-Neumann, Ralf Dunkel
  • Publication number: 20080267846
    Abstract: Processes comprising: providing a crude gas comprising hydrogen chloride and at least one sulfur compound; and passing the crude gas across a sacrificial material such that at least a portion of the at least one sulfur compound is oxidized and precipitated as sulfate onto the sacrificial material to provide a hydrogen chloride product gas.
    Type: Application
    Filed: April 28, 2008
    Publication date: October 30, 2008
    Applicant: Bayer MaterialScience AG
    Inventors: Michel Haas, Knud Werner
  • Publication number: 20080269051
    Abstract: The invention relates to active compound combinations comprising firstly the known fluoxastrobin and secondly further known fungicidal active compounds, which combinations are highly suitable for controlling unwanted phytopathogenic fungi.
    Type: Application
    Filed: October 11, 2005
    Publication date: October 30, 2008
    Applicant: BAYER CORPSCIENCE AG
    Inventors: Anne Suty-Heinze, Friedrich Kerz-Mohlendick, Stefan Dutzmann, Ulrich Heinemann